Virtus Fund Advisers’s Array Biopharma Inc ARRY Stock Holding History

Virtus Fund Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$834K	Buy	65,159 +29,312	+82%	+$333K	0.01%	307
2017 Q3	$441K	Sell	35,847 -2,232	-6%	-$20.7K	﹤0.01%	295
2017 Q2	$318K	Sell	38,079 -1,137	-3%	-$9.3K	﹤0.01%	366
2017 Q1	$351K	Sell	39,216 -27,857	-42%	-$296K	﹤0.01%	366
2016 Q4	$590K	Hold	67,073	–	–	0.01%	316
2016 Q3	$453K	Hold	67,073	–	–	﹤0.01%	344
2016 Q2	$243K	Hold	67,073	–	–	﹤0.01%	386
2016 Q1	$198K	Sell	67,073 -14,518	-18%	-$43.5K	﹤0.01%	396
2015 Q4	$344K	Sell	81,591 -858	-1%	-$3.92K	﹤0.01%	368
2015 Q3	$376K	Sell	82,449 -122,584	-60%	-$727K	﹤0.01%	356
2015 Q2	$1.48M	Buy	+205,033	New	+$1.51M	0.01%	335
2014 Q3	–	Sell	-10,750	Closed	-$49K	–	2287
2014 Q2	$49K	Buy	+10,750	New	+$44.5K	﹤0.01%	1888

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Virtus Fund Advisers's ARRY Position: Q4 2017 in Review

Virtus Fund Advisers increased its Array Biopharma Inc (ARRY) stake by 82% in Q4 2017, buying an estimated $333K and bringing the position to 65,159 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #307.

Virtus Fund Advisers first reported a position in ARRY in Q2 2014 and has held it in 12 quarters since. The position peaked at $1.48M in Q2 2015. 191 funds tracked by Wall St. Rank hold ARRY as of Q4 2017.

Virtus Fund Advisers held 65,159 shares of Array Biopharma Inc worth $834K as of Q4 2017.
Virtus Fund Advisers bought 29,312 Array Biopharma Inc shares in Q4 2017, an estimated $333K.
Array Biopharma Inc made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #307 holding.
Virtus Fund Advisers first reported a position in Array Biopharma Inc in Q2 2014 and has held it in 12 quarters since.
Virtus Fund Advisers's Array Biopharma Inc position peaked at $1.48M in Q2 2015.
191 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.